Investor Presentaiton slide image

Investor Presentaiton

PolyPeptide with >70 years experience in peptide manufacturing Global footprint with GMP-certified sites for services across development phases Company Snapshot A global market leader for innovative clinical and commercial stage peptide drug substances Dedicated peptide API manufacturer, producing around one half of all currently approved peptide drug substances 70+ years of specialized, accumulated know-how in peptides Long-term partner from start-up to large pharmaceutical customers COMPREHENSIVE SERVICES FOR COMPLEX PEPTIDES Custom Projects Contract Manufacturing Generics & Cosmetics 1'026 GLOBAL SUPPORT FOR A QUALITY SOLUTION Network of specialized sites with experienced teams Employees by experience 40% <2 years 25% 2 to 10 years 35% >10 years Full-time equivalents as per 30 June 2021 6 Braine-l'Alleud, BE Malmö, SE Torrance, CA Zug, CH Strasbourg, FR San Diego, CA Ambernath, IN PolyPeptide GROUP
View entire presentation